Working… Menu

CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00576225
Recruitment Status : Withdrawn
First Posted : December 19, 2007
Last Update Posted : October 19, 2020
Information provided by (Responsible Party):
CTI BioPharma

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : April 5, 2010
Actual Study Completion Date : April 5, 2010